120 related articles for article (PubMed ID: 31314707)
1. ANKRD33 is overexpressed in gastric adenocarcinoma and predictive for poor prognosis.
Li QH; Yu M; Ding YL; Chen YX
Biosci Biotechnol Biochem; 2019 Nov; 83(11):2075-2081. PubMed ID: 31314707
[TBL] [Abstract][Full Text] [Related]
2. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
3. The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance.
Zhu X; Liu J; Xu X; Zhang C; Dai D
Int J Oncol; 2015 Jan; 46(1):195-204. PubMed ID: 25355626
[TBL] [Abstract][Full Text] [Related]
4. IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2.
Huang J; Chen YX; Zhang B
Gastric Cancer; 2020 Jan; 23(1):23-38. PubMed ID: 31183590
[TBL] [Abstract][Full Text] [Related]
5. SAMD4A serves as a negative prognostic marker for gastric cancer patients.
Li D; Qi T; Chen J
Tissue Cell; 2023 Oct; 84():102167. PubMed ID: 37515967
[TBL] [Abstract][Full Text] [Related]
6. FKBP10 functioned as a cancer-promoting factor mediates cell proliferation, invasion, and migration via regulating PI3K signaling pathway in stomach adenocarcinoma.
Wang RG; Zhang D; Zhao CH; Wang QL; Qu H; He QS
Kaohsiung J Med Sci; 2020 May; 36(5):311-317. PubMed ID: 31868996
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
[TBL] [Abstract][Full Text] [Related]
8. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway.
Wang X; Gao S; Xie F; Li W; Li M; Yan N; Gao T; Fang L
J Cell Biochem; 2019 Aug; 120(8):13903-13911. PubMed ID: 30982999
[TBL] [Abstract][Full Text] [Related]
9. Verification of expressions of lncRNA FOXCUT in gastric adenocarcinoma patients and its effects on cell biological function based on TCGA database.
Zhao DL; Shen G
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6139-6147. PubMed ID: 31364114
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin is associated with a prognosis of gastric adenocarcinoma.
Zhou CL; Su HL; Dai HW
Rev Assoc Med Bras (1992); 2020 May; 66(5):590-595. PubMed ID: 32638965
[TBL] [Abstract][Full Text] [Related]
11. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.
Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q
Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181
[TBL] [Abstract][Full Text] [Related]
12. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
[TBL] [Abstract][Full Text] [Related]
13. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
14. miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway.
Wu Y; Tian S; Chen Y; Ji M; Qu Y; Hou P
Pathol Res Pract; 2019 Feb; 215(2):243-250. PubMed ID: 30420101
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis.
Huang CY; Chen YM; Zhao JJ; Chen YB; Jiang SS; Yan SM; Zhao BW; Pan K; Wang DD; Lv L; Li YF; Wang W; Zhou ZW; Xia JC
PLoS One; 2013; 8(1):e54671. PubMed ID: 23372750
[TBL] [Abstract][Full Text] [Related]
16. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression.
Zhang J; Xu J; Dong Y; Huang B
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29899167
[TBL] [Abstract][Full Text] [Related]
18. RPS15a Silencing Suppresses Cell Proliferation and Migration of Gastric Cancer.
Shi D; Liu J
Yonsei Med J; 2018 Dec; 59(10):1166-1173. PubMed ID: 30450850
[TBL] [Abstract][Full Text] [Related]
19. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway.
Ao R; Guan L; Wang Y; Wang JN
J Cell Biochem; 2018 Jun; 119(6):4420-4434. PubMed ID: 29143985
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.
Chen YJ; Wu H; Zhu JM; Li XD; Luo SW; Dong L; Liu TT; Shen XZ
J Gastroenterol Hepatol; 2016 Jan; 31(1):155-63. PubMed ID: 26173586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
